Works matching IS 09697128 AND DT 2002 AND VI 9 AND IP 5

Results: 7

Transient suppression of transgene expression by means of antisense oligonucleotides: a method for the production of toxin-transducing recombinant viruses.
Published in:
Gene Therapy, 2002, v. 9, n. 5, p. 358, doi. 10.1038/sj.gt.3301660
By:
- Raykov, Z.;
- Legrand, V.;
- Homann, H.E.;
- Rommelaere, J.
Publication type:
Article
Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
Published in:
Gene Therapy, 2002, v. 9, n. 5, p. 353, doi. 10.1038/sj.gt.3301662
By:
- Gautam, A.;
- Waldrep, J.C.;
- Densmore, C.L.;
- Noshkina, N.;
- Melton, S.;
- Roberts, L.;
- Gilbert, B.;
- Knight, V.
Publication type:
Article
An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53.
Published in:
Gene Therapy, 2002, v. 9, n. 5, p. 345, doi. 10.1038/sj.gt.3301670
By:
- Nikitina, E.Y.;
- Chada, S.;
- Muro-Cacho, C.;
- Fang, B.;
- Zhang, R.;
- Roth, J.A.;
- Gabrilovich, D.I.
Publication type:
Article
Improved co-expression of multiple genes in vectors containing internal ribosome entry sites (IRESes) from human genes.
Published in:
Gene Therapy, 2002, v. 9, n. 5, p. 337, doi. 10.1038/sj.gt.3301667
By:
- Wong, E.T.;
- Ngoi, S.-M.;
- Lee, C.G.L.
Publication type:
Article
LCR-mediated, tong-term tissue-specific gene expression within replicating episomal plasmid and cosmid vectors.
Published in:
Gene Therapy, 2002, v. 9, n. 5, p. 327, doi. 10.1038/sj.gt.3301654
By:
- Chow, C.-M.;
- Athanassiadou, A.;
- Raguz, S.;
- Psiouri, L.;
- Harland, L.;
- Malik, M.;
- Aitken, M.A.;
- Grosveld, F.;
- Antoniou, M.
Publication type:
Article
Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.
Published in:
Gene Therapy, 2002, v. 9, n. 5, p. 320, doi. 10.1038/sj.gt.3301680
By:
- Bainbridge, J.W.B.;
- Mistry, A.;
- De Alwis, M.;
- Paleolog, E.;
- Baker, A.;
- Thrasher, A.J.;
- Ali, R.R.
Publication type:
Article
Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratinocytes.
Published in:
Gene Therapy, 2002, v. 9, n. 5, p. 307, doi. 10.1038/sj.gt.3301656
By:
- Mhashilkar, A.M.;
- Doebis, C.;
- Seifert, M.;
- Busch, A.;
- Zani, C.;
- Soo Hoo, J.;
- Nagy, M.;
- Ritter, T.;
- Volk, H.-D.;
- Marasco, W.A.
Publication type:
Article

Works matching IS 09697128 AND DT 2002 AND VI 9 AND IP 5

Transient suppression of transgene expression by means of antisense oligonucleotides: a method for the production of toxin-transducing recombinant viruses.

Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.

An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53.

Improved co-expression of multiple genes in vectors containing internal ribosome entry sites (IRESes) from human genes.

LCR-mediated, tong-term tissue-specific gene expression within replicating episomal plasmid and cosmid vectors.

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.

Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratinocytes.